Relation of depression to various markers of coagulation and fibrinolysis in patients with and without coronary artery disease

Abstract

Our study gives no evidence that there is a significant relation among depression, CAD, and blood coagulation and fibrinolysis.

C-reactive protein and fibrinogen in non-obstructive coronary artery disease as related to depressive symptoms and anxiety: Findings from the TweeSteden Mild Stenosis Study (TWIST)

“…Using mediation analysis, these studies showed that factors of an unhealthy lifestyle; increased BMI or weight gain, smoking and being inactive, explained the association between CRP levels and depressive symptoms. The finding that both depression and anxiety were not related to fibrinogen levels are not consistent with some previous reports [20], but is in line with others [12,14]. Relatively small effect sizes have been observed in a cohort with people with clinical depression; with adjusted models showing that current depression in men, but not women, was associated with CRP [21].…”

“…Patients were contacted via mail or telephone within three months after CAG or CT. Questionnaires were sent and returned by postal mail. Hospital records were screened for clinical information and blood was collected at the hospital during morning office hours (8)(9)(10)(11)(12). The study was performed in accordance with the declaration of Helsinki and approved by the local Institutional Review Board (Protocol number: NL22258.008.08).…”

“…A dysregulated immune system and impaired response to injury has been hypothesized as one of the underlying mechanisms involved in the associations between psychosocial factors and the development of CAD and the progression of stable CAD to acute coronary syndromes [6][7][8][9][10]. Several studies have found a direct association of heightened circulating levels of the acute phase reactants high sensitive C-reactive protein (hs-CRP) and fibrinogen with acute cardiac events [11,12]. Recently, Elderon & Whooley proposed an interconnected system which links depression, health behavior and biological changes to increased risk of CAD and its clinical manifestations [13].…”

Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome

“…However, in several other studies of ACS populations, D-dimer levels did not yield prognostic information. [37][38][39][40] In the present population, D-dimer showed no independent prognostic utility at 2 years of follow-up, 28 but gained prognostic importance during the extended follow-up period, reflecting a gradual progression of disease from silent to clinically evident thrombotic manifestations. In contrast to PTX3, hsCRP did not appear to be an independent predictor of total mortality in our multivariate analysis, but its level was associated with recurrent MI during the follow-up period.…”

The association of depressive symptoms with cardiovascular and all-cause mortality in Central and Eastern Europe: Prospective results of the HAPIEE study

“…via increased platelet activity, inflammation, alterations in the hypothalamic–pituitary–adrenal axis or increased activity of the sympathetic nervous system). 4–8 However, the causal role of depression remains debated because the observational evidence is not entirely consistent 9 and because experimental studies of the effects of depression treatment on cardiovascular outcomes produced ambiguous results. 10–13 Another question relates to whether mortality is associated only with severe depression or whether it is also predicted by milder symptoms of psychological distress.…”